VULNERABILITY INDEX PROGRAM

Details for Australian Trade Mark No. 1112022 (hide)

Owner Bristol-Myers Squibb Company a Delaware corporation

Convention US, 11 Jan 2006

Service Spruson & Ferguson

Various Convention priority claimed: 11 January 2006, United States of America, No. 78/789305 in respect of MEDICAL AND SCIENTIFIC RESEARCH, NAMELY, CONDUCTING CLINICAL TRIALS TO ASSESS VULNERABLE OR RUPTURE PRONE CORONARY PLAQUES.*

Classes

Class 42 Medical and scientific research, including conducting clinical trials to asess vulnerable or rupture prone coronary plaques

Event Publications

18 May 2006 Application filed

4 October 2007 Application Lapsed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1112023-LA SERENISIMA

1112021-GREXLO